Nanocomplexes of an insulinotropic drug: optimization, microparticle formation, and antidiabetic activity in rats
Enas Elmowafy, Rihab Osman, Abdel Hameed El-Shamy,† Gehanne AS AwadDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt†Abdel Hameed El-Shamy passed away on August 25, 2013Abstract: The aim of the present work was to test...
Guardado en:
Autores principales: | Elmowafy E, Osman R, El-Shamy AH, Awad GAS |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/84d21960c278436cb2a35685b5d73443 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optimizing weight control in diabetes: antidiabetic drug selection
por: S Kalra, et al.
Publicado: (2010) -
Optimizing weight control in diabetes: antidiabetic drug selection
por: Kalra S
Publicado: (2010) -
Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Chris Wai Hang Lo, et al.
Publicado: (2021) -
Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
por: Elizabeth A. Killion, et al.
Publicado: (2020) -
Antidiabetic activity enhancement in streptozotocin + nicotinamide–induced diabetic rats through combinational polymeric nanoformulation
por: Rani R, et al.
Publicado: (2019)